UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Details
Sales, net	$ 10,390	$ 10,125	$ 32,242	$ 31,213
Cost of goods sold	4,096	3,629	12,042	11,288
Gross profit	6,294	6,496	20,200	19,925
Operating expense
Selling, general and administrative	1,784	1,714	5,433	5,146
Research & development	108	103	338	341
Total operating expenses	1,892	1,817	5,771	5,487
Operating income	4,402	4,679	14,429	14,438
Other income (expense)	79	17	617	65
Income before provision for income taxes	4,481	4,696	15,046	14,503
Provision for income taxes	(2,281)	1,074	(116)	3,476
Net income	$ 6,762	$ 3,622	$ 15,162	$ 11,027
Earnings per common share (basic)	$ 1.81	$ 0.97	$ 4.07	$ 2.97
Earnings per common share (diluted)	$ 1.80	$ 0.97	$ 4.04	$ 2.95
Shares outstanding - basic	3,733	3,719	3,730	3,716
Shares outstanding - diluted	3,753	3,738	3,752	3,734
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ (385)	$ 1,223	$ (1,920)	$ 3,559
Total comprehensive income	$ 6,377	$ 4,845	$ 13,242	$ 14,586